Industrial Policy & Trade Monitor· 2663 actions· ✨ 89 recent

India and New Zealand signed their first bilateral Free Trade Agreement on 27 April 2026 in New Delhi. New Zealand grants duty-free access to 100% of Indian exports from day one, while India eliminates tariffs on ~95% of New Zealand exports — covering kiwifruit, apples, meat, wool, coal and forestry products — with core dairy (butter, cheese) carved out and milk albumins receiving a 50% tariff cut under quota. Negotiations launched in March 2025 and were concluded in 9 months. The package includes a NZ commitment to invest USD 20 billion in India over 15-20 years and ~5,000 annual Indian work visas for IT, engineering, healthcare, education, construction, traditional medicine, yoga and culinary professions; bilateral trade is targeted to double to USD 5 billion within five years. The agreement is signed but not yet in force pending ratification.

Brazil's Foreign Trade Chamber Executive Committee (GECEX/CAMEX) adopted Resolução GECEX nº 855 on 13 February 2026, imposing a five-year definitive antidumping duty on hypodermic needles (agulhas hipodérmicas) originating from China, classified under NCM tariff code 9018.32.19 (other tubular metal needles). The duty is collected as a specific tariff fixed in US dollars per thousand units, with rates ranging from USD 0.23 to USD 25.57/thousand units depending on the Chinese producer/exporter. The measure was published in the Diário Oficial da União (DOU Edição 32) on 18 February 2026, enters into force from publication, and marks the first medical-device trade-remedy action on the IPTM register. Scope exclusions cover insulin needles, biopsy needles, animal insemination needles, anesthesia needles, bulk non-sterile needles, and non-hypodermic needles.

China's Ministry of Finance, Ministry of Commerce, People's Bank of China and National Financial Regulatory Administration jointly issued Cai Jin [2026] No. 5 on 2026-01-19, optimizing the service-sector loan interest-subsidy policy first launched in August 2025 (Cai Jin [2025] No. 81). The notice extends the scheme through 2026-12-31, raises the per-entity eligible new-loan cap for 2026 to RMB 10 million (subsidy period capped at one year, annual subsidy rate of 1 percentage point, funded 90% by central and 10% by provincial finances), and widens covered sectors from the original eight (catering/accommodation, health, eldercare, childcare, domestic services, culture/entertainment, tourism, sports) to add digital, green and retail categories. It also expands the roster of handling banks to a longer list of state and joint-stock commercial banks.

At its 30 December 2025 regular session, Iraq's Council of Ministers, chaired by Prime Minister Mohammed Shia' Al-Sudani, approved two additional customs duties on imports from all countries of origin: a 40% additional duty on medical and industrial oxygen (gaseous and liquid forms), in effect for four years, and a 30% additional duty on imported yogurt (laban rayeb) and liquid milk. Both measures were framed as protecting domestic pharmaceutical/ industrial-gas production and local dairy manufacturing respectively, and take effect 120 days after issuance (29 April 2026) to give importers an adjustment window. Global Trade Alert logs the dairy duty as principally affecting Germany, Saudi Arabia and Türkiye as leading supplier origins, though the measure itself is non-discriminatory (applies to all origins).

The Bank of Thailand and Ministry of Finance, together with the Thai Bankers' Association and Association of International Banks, launched "SMEs Credit Boost," a THB 20 billion (~USD 580 million) new loan-guarantee facility funded through a temporary reduction in commercial banks' 2026 FIDF (Financial Institutions Development Fund) contribution rather than new fiscal spending. The scheme guarantees 15-30% of new bank lending to SMEs and qualifying larger firms in government-prioritised "Reinvent Thailand" sectors, is projected to catalyse roughly THB 100 billion in new credit over 1-2 years, and took effect 2026-01-15.

Taiwan's Legislative Yuan passed the Artificial Intelligence Basic Act (人工智慧基本法) on third reading on 23 December 2025, and President Lai Ching-te promulgated the 20-article statute on 14 January 2026, bringing it into force immediately. The Act designates the National Science and Technology Council (NSTC) as the central AI-policy competent authority and codifies seven governance principles — sustainability and well-being, human autonomy, privacy protection and data governance, cybersecurity and safety, transparency and explainability, fairness and non-discrimination, and accountability — that apply to all public-sector AI procurement and high-risk sectoral applications. The statute establishes a statutory foundation for the Taiwan AI Action Plan 2.0, mandates an Executive Yuan National AI Strategy Committee, and provides authority for sector-specific implementing regulations by FSC, NCC, MOHW, and MOTC across finance, telecoms, medical, and autonomous-vehicle AI within a two-year window. As the first national AI governance statute in the Greater China region and the third globally after the EU AI Act and South Korea's AI Basic Act, it frames regulatory expectations for the companies at the heart of the global AI hardware supply chain — TSMC, NVIDIA ODM partners, and advanced-packaging incumbents — that are headquartered or operate substantially in Taiwan.

On 24 November 2025, six Beijing municipal departments — the Bureau of Economy and Information Technology, Development and Reform Commission, Science and Technology Commission, Health Commission, Drug Administration and Medical Insurance Bureau — jointly issued Notice 京经信发〔2025〕50号 ("Several Measures to Promote High-Quality Development of the Beijing Medical Device Industry"), effective immediately through 31 December 2028. The 15-measure package subsidises the full medical-device value chain: early-stage innovation (up to RMB 1m per project), product approval/launch (up to RMB 2m per product, RMB 10m annual enterprise cap), industrial-park and public-service infrastructure construction (up to 50% of investment, capped at RMB 50m), supply-chain-resilience R&D for critical components/materials (up to 30% of investment, capped at RMB 30m), AI-diagnostic-model development (up to RMB 30m), smart-factory digitalisation (up to 30% of investment, capped at RMB 30m per project), and international regulatory approval/market entry (up to RMB 1m per product, RMB 3m annual cap; up to RMB 10m for introducing overseas products to China).

On 31 October 2025, Japan Investment Corporation (JIC) and its subsidiary JIC Capital, Ltd. (JICC) announced the establishment of two new private-equity limited partnerships — JIC PEF2 (JPY600 billion) and JIC PEFJ2 (JPY200 billion), collectively "JIC PE2" and totalling approximately JPY800 billion (~USD 5.36 billion) — launching 1 November 2025. The funds provide state-backed risk capital for large-scale industry restructuring, growth investment, and business-restructuring deals in capital-intensive sectors (mobility, semiconductors, chemicals, materials, healthcare) where JIC judges private PE capital in Japan to be insufficient. PEF2 is the main investment vehicle (10-year term, 5-year investment period); PEFJ2 co-invests alongside PEF2 in large-scale projects.

Italy enacted Legge 23 settembre 2025, n. 132 — "Disposizioni e deleghe al Governo in materia di intelligenza artificiale" — published in Gazzetta Ufficiale Serie Generale n. 223 of 25 September 2025 (atto 25G00143) and entered into force on 10 October 2025. The statute makes Italy the first EU member state to enact a comprehensive national AI law complementing Regulation (EU) 2024/1689 (EU AI Act), designating AgID (Agency for Digital Italy) and ACN (National Cybersecurity Agency) as national oversight authorities under Presidency-of-the-Council-of-Ministers coordination. It sets sectoral rules for healthcare, labour, intellectual professions, public administration and the judiciary; authorises up to €1 billion in state-backed venture capital (via CDP Venture Capital) for AI, cybersecurity and telecoms; creates criminal penalties of up to five years' imprisonment for harmful deepfakes; mandates parental consent for under-14 users; and delegates secondary legislation to the Government across multiple domains.

On 18 September 2025, as part of the third phase of France's national AI strategy under the France 2030 programme, the government opened the "Pionniers de l'intelligence artificielle" (Pioneers of AI) call for projects, operated by Bpifrance and the NALU ("Numérique, Algorithmes, Logiciels et Usages") agency program led by Inria. The scheme funds disruptive AI technologies and applications across industrial robotics, healthcare, energy production/distribution and manufacturing through a three-phase funnel: Phase 1 (technical feasibility, EUR 100k-200k over 6-12 months), Phase 2 (demonstrator, EUR 400k-800k over 6-18 months) and Phase 3 (market launch, EUR 3-8M over 1-3 years), with projects re-vetted for technological and economic relevance between phases. Submissions run 11 September 2025 to 9 June 2026 across multiple deadline windows; as of the government's 18 June 2026 update, 51 projects (23 in a first round, 28 in a second) had been selected, including firms such as IMIND (microelectronics), Skipper NDT, Sagacity Health, Lutece Dynamics, HyprView, DeepLife, Phagos and Wintics, alongside multiple Inria-led projects.

On 17 September 2025 the General Office of the Shanghai Municipal People's Government issued Hufubangui [2025] No. 8, a five-year (26 September 2025 - 25 September 2030) state-aid framework to accelerate frontier-technology innovation and cultivate "future industries" across six domains — future manufacturing, future information, future materials, future energy, future space and future health. Targeted technology areas include cell and gene therapy, brain-computer interfaces, biomanufacturing, embodied intelligence (humanoid robotics/AI hardware), fourth-generation semiconductors, silicon photonics, 6G, neuromorphic computing, quantum technology, controlled nuclear fusion and regenerative medicine. Support is disbursed as tiered direct subsidies rather than tax relief, with named ceilings up to CNY 30 million per proof-of-concept/R&D platform and CNY 20 million per high-quality incubator or first-product/batch innovation award.

The European Investment Bank (EIB) signed a EUR 400 million loan agreement with Fresenius on 8 September 2025 in Bad Homburg, Germany, to finance research, development and innovation activities and capacity expansion for Fresenius Kabi's manufacturing of biosimilars, generic drugs, infusion therapies, clinical nutrition products, and associated medical devices across EU member states. The financing is explicitly framed by both parties as strengthening the resilience of European pharmaceutical production and security of supply for EU healthcare systems.

Act L of 2025 (2025. évi L. törvény) is the Hungarian National Assembly statute that elevates a set of war-emergency government decrees — including the foreign-investment screening regime previously embedded in Government Decree 561/2022 — to permanent statutory level. Promulgated in Magyar Közlöny and entered into force on 19 August 2025, the Act preserves Hungary's "Second Regime" of FDI screening operating in parallel with the General Regime (which implements EU Reg 2019/452 since 2019). The Second Regime applies to a broad set of strategic sectors — energy, transport, communications, telecoms, pharmaceuticals, food processing, defence, financial services and healthcare — and requires approval from the Minister of National Economy for qualifying acquisitions (direct or indirect majority, ≥5% interest, ≥3% in listed companies, or ownership/operation of strategic infrastructure) where transaction value reaches HUF 350 million (~EUR 890,000). Notification is due within 10 days of signing; the MoE originally had 30 business days (extendable +15 calendar days). The Act also entrenches the Hungarian state right of first refusal on photovoltaic generation companies (NACE 35.11'08, excluding sub-50 kVA household installations), exercised through MNV Zrt. The Special Regime is structurally distinct from the General Regime and represents Hungary's peer to the German AWG §§55-62, French Décret 2014-479, Dutch Wet Vifo, and Italian Golden Power. Amended by Act XCIII of 2025 (in force 17 December 2025), which extended the MoE screening deadline to 45 business days and excluded bank-financing security arrangements from notification.

On 5 August 2025 the municipal government of Xianning (Hubei Province) launched the "Hubei-Xianning High-Tech Industry Regional Mother Fund" (湖北咸宁高新产业区域母基金) at a launch ceremony attended by a Hubei provincial Finance Department official and Xianning's executive vice mayor. The fund was jointly capitalised by the Hubei Provincial Government Guidance Fund, Changjiang Growth Capital, the Xianning Municipal Government Guidance Fund, Xianning Chengfa Group, and Xianning Gaotou Group at a total scale of CNY 3 billion (~USD 420 million), the first city-level regional mother fund set up under Hubei's provincial guidance-fund restructuring programme. It operates a "sub-fund + direct project investment" model and is projected to leverage CNY 15 billion in social capital toward Xianning's "5+5" modern industrial system (big health, electronic information, clean energy, and new materials, among other priority sectors). At launch it signed cooperation-intent agreements with 5 sub-funds (CNY 2 billion combined scale) and investment agreements with 5 enterprises (CNY 200 million combined).

Czech Act No. 265/2025 Sb., promulgated in the Sbírka zákonů on 4 August 2025 and entering into force on 1 November 2025, is the first material amendment of the Czech Republic's foundational FDI screening statute (Act No. 34/2021 Sb.) since its enactment. The amendment broadens the perimeter of mandatory pre-closing FDI screening by cross-referencing the simultaneously-enacted Cybersecurity Act (Act No. 264/2025 Sb., transposing NIS2 Directive 2022/2555): entities designated as providers of "regulated services" under the Cybersecurity Act's "regime of higher obligation" automatically fall within mandatory FDI-screening scope, extending screening reach beyond the prior military-material / dual-use / critical-infrastructure perimeter to cover a broad sweep of digital, technology, healthcare, energy, and financial-services operators. The amendment also adds a confidentiality-sharing channel between MPO and NÚKIB, enabling coordinated supply-chain-security assessments for high-risk-vendor reviews under the new Cybersecurity Act.

Brazil's Inter-Ministerial Commission for Novo PAC Innovations and Acquisitions (CIIA-PAC/CC), under the Casa Civil, published Resolução CIIA-PAC/CC nº 3, de 28 de julho de 2025 in the Diário Oficial da União on 2025-07-31. The resolution designates a list of manufactured healthcare equipment (primary and specialised care items, e.g. vaccine cold-storage units, digital retinographs, electrocautery devices, defibrillators, surgical tables, anesthesia machines, rigid videoendoscopy systems) that qualifies for a public -procurement preference margin under Decreto nº 11,889/2024 and Art. 26 of Lei nº 14,133/2021. Qualifying domestically manufactured products can win public tenders even when priced 10-20% above imported equivalents, provided the manufacturer holds BNDES Finame accreditation and meets national-technology (TECNAC) content criteria. The measure accompanies an announced BRL 2.4 billion government purchase of over 10,000 healthcare equipment units for Brazil's public health system (SUS).

On 28 July 2025 the General Office of the Shanghai Municipal People's Government issued Hufubangui [2025] No. 6, the "Shanghai Embodied Intelligence Industry Development Implementation Plan" (上海市具身智能产业发展实施方案), a dedicated municipal state-aid package to build Shanghai into a global innovation hub for embodied intelligence (humanoid robotics / physical AI). The plan targets an industry scale of CNY 500 billion by 2027, alongside at least 20 core algorithm/technology breakthroughs, four or more high-quality incubators, and "100-100-100" targets for leading enterprises, applications and products. Support is disbursed as tiered direct subsidies capped at CNY 50 million (30% of project cost) for core-technology R&D, CNY 40 million per company per year for computing-power credits, CNY 20 million (50% of cost) for public-platform construction, CNY 10 million (20% of cost) for application-demonstration projects, CNY 5 million per company per year for language-corpus services, CNY 5 million (5% of contract value) for robot sales/rental incentives, CNY 5 million per open-source project, and CNY 1 million per leading enterprise for standards development. Target application sectors are logistics, industrial manufacturing, retail, healthcare/eldercare and domestic services.

The European Investment Bank signed a EUR 150 million loan agreement with Italian pharmaceutical group Alfasigma SpA on 8 July 2025 to finance the company's 2025-2027 research and development programme in rare diseases and specialty care (gastroenterology/hepatology, vascular medicine, rheumatology). The EIB framed the operation as part of its agenda to bolster competitiveness and innovation in the European healthcare sector. Global Trade Alert logged the announcement and implementation date as 27 June 2025 (state-act 92597); the EIB's own press release places the signing on 8 July 2025.

Brazil's national development bank BNDES approved a BRL 100 million (~USD 18 million) financing package for BRQ Digital Solutions, funded through the BNDES Mais Inovação program, to build 17 technical accelerators for the company's proprietary generative-AI platform "Fusion BRQ." The operation is aligned with Mission 4 (Digital Transformation) of Nova Indústria Brasil, the federal government's industrial policy, and is projected to create roughly 60 new R&D jobs. The AI platform targets accelerated software development across finance, healthcare, energy, insurance, retail, agriculture and telecom client sectors.

Government Decree 163/2025 (VI. 23.) amends the emergency-era Decree 561/2022 (XII. 23.) on economic-protection deviations, making two operative changes to Hungary's FDI screening regime: it extends the review period from 30 to up to 135 working days (45-day base plus three 30-workday extensions) and introduces a state pre-emption right, exercisable within 90 calendar days of a prohibition decision, allowing MNV Zrt. (Hungarian National Asset Management Company) or a designated entity to acquire the blocked target on the same terms as the original parties. The decree applies retroactively to all notification procedures pending at the time of entry into force (24 June 2025) and expands the screening scope from a solar-sector focus to broad strategic sectors. It served as an interim bridge — in force from 24 June to 18 August 2025 — until superseded by the permanent statutory codification in Act L of 2025.

On 11 June 2025, at the second Belt and Road Science and Technology Exchange Conference in Chengdu, Sichuan Province formally launched the "Sichuan Sci-Tech Achievement Transformation Investment Guidance Fund" (四川省成果转化投资引导基金) with a total scale of CNY 5 billion (~USD 700 million). The fund is capitalised 40% by the Sichuan Provincial Industrial Investment Guidance Fund, 40% by other in-province state funds, and 20% by capital raised from outside the province. It targets "invest early, invest small, invest in hard tech" bets across seven priority areas — tech/communications, new materials, advanced manufacturing, clean energy, medical and pharmaceutical, energy conservation/environmental protection, and specialised industries — aligned to Sichuan's "15+N" priority industrial-chain plan. Seven sub-funds (one seed-stage, three angel-stage, three venture-stage) totalling CNY 4.05 billion were already established at launch, and the fund's operator (Sichuan Industrial Revitalization Fund Investment Group) stated a 2025 investment target of over CNY 500 million, with CNY 150 million already committed across 4 AI and energy-equipment projects and a further CNY 390 million quasi-approved across 10 projects.

On 2025-06-02 Mexico published a presidential decree ("DECRETO por el que se fomenta la inversión en territorio nacional, para fortalecer el desarrollo de la industria farmacéutica y la producción de insumos para la salud; así como el desarrollo de investigación científica nacional") in the Diario Oficial de la Federación, effective 2025-06-03. Starting with fiscal-year 2026 consolidated federal purchases of medicines, health inputs and medical devices (for 2027 delivery), the Secretaría de Salud will apply a points-and-percentage evaluation scheme that favors bidders holding productive investment or infrastructure (plants, laboratories, warehouses) in Mexico, or that conduct scientific research domestically. A tri-ministry Promotion Committee (Health, Economy, and the Anticorruption/Public Function ministry) will vet investment commitments, and the decree directs the Secretaría de Salud to issue implementing guidelines within 90 calendar days of publication.

Greece enacted Law 5202/2025 on 22 May 2025, published in Government Gazette ΦΕΚ A' 84 on 23 May 2025 and effective the same day, establishing the country's first national mandatory and suspensory foreign direct investment screening mechanism, aligned with Regulation (EU) 2019/452. The Interministerial Committee for the Control of Foreign Direct Investment (ICC-FDI), with initial procedure run by the Ministry of Foreign Affairs, reviews non-EU acquisitions in "sensitive" sectors (energy, transportation, healthcare, ICT, digital infrastructure) and "particularly sensitive" sectors (national security, defence, cybersecurity, AI, ports and critical subsea infrastructure, borderland tourism). A two-phase review applies — 30 days Phase I, up to 150 days Phase II with EU Cooperation Mechanism notification — and the regime became fully operational on 11 November 2025.

On 19 May 2025, Emirates Development Bank (EDB) launched the Emirates Growth Fund (EGF), an AED 1 billion (~USD 272 million) growth-equity platform targeting UAE-based SMEs with annual revenues of AED 10 million or more operating in four national priority sectors: manufacturing, food security, healthcare, and advanced technology. EGF takes active minority equity stakes, typically deploying AED 10-50 million in primary capital per company, to fill the "missing middle" between early-stage venture funding and traditional private equity. The fund forms part of EDB's broader financing portfolio supporting the UAE's Operation 300bn industrial strategy.

President Trump signed Executive Order 14273, "Delivering Most- Favored-Nation Prescription Drug Pricing to American Patients", on 12 May 2025. The EO directs HHS, USTR, and Commerce to pursue mechanisms (negotiation targets, importation pathways, and trade-policy levers) to bring the prices Americans pay for innovative prescription drugs into alignment with the *lowest* prices paid by other comparably-developed nations — the "most-favored-nation" (MFN) benchmark. Unlike the Biden-era Inflation Reduction Act drug-price-negotiation provisions (which apply to a handful of Medicare Part D drugs), the EO applies pressure across the broader pharmaceutical pricing surface. As of April 2026, 17 major pharmaceutical manufacturers (incl. Eli Lilly, Pfizer, Bristol-Myers Squibb, AbbVie, Merck, AstraZeneca, Regeneron) have signed bilateral agreements bringing US drug prices toward the international- benchmark level for selected medications.

On 29 April 2025 Brazil's Federal Senate approved two external credit operations, both backed by a Union guarantee, authorizing the national development bank BNDES to raise a combined ~BRL 2.6 billion (~USD 460m). USD 250m (~BRL 1.4bn) comes from the Inter-American Development Bank (IDB) to fund the BID-BNDES Program for Sustainable and Productive Recovery of MSMEs, prioritising women-led, vulnerable-area and sustainability-linked enterprises that have not yet recovered from COVID-19. JPY 30bn (~BRL 1.2bn) comes from Japan's JICA, split up to JPY 12bn (~BRL 480m) for the medical/health sector and up to JPY 18bn (~BRL 720m) for MSMEs across other sectors, at a concessional 0.01%/year interest rate, 180-month total term and 4-year grace period. Effective the same day as Senate approval; BNDES on-lends the funds via its standard repasse network of accredited financial institutions.

Bpifrance, France's state-owned public investment bank, took a 1.8% equity stake with board representation in Opella — the Sanofi-spun-off consumer healthcare unit that makes Doliprane (paracetamol) and other OTC brands — as part of the closing of Sanofi's sale of a 50% controlling stake to US private equity firm Clayton, Dubilier & Rice (CD&R). Sanofi retains 48.2%. The stake was widely read domestically as a state sovereignty guarantee attached to a politically contentious foreign takeover of a company regarded as critical to French medicine supply security.

The Nigeria Data Protection Commission issued the General Application and Implementation Directive (GAID) 2025 on 20 March 2025, the principal implementing directive of the Nigeria Data Protection Act 2023 (NDPA). The GAID came fully into force on 19 September 2025, replacing the Nigeria Data Protection Regulation (NDPR) 2019 as the operative enforcement instrument. It applies extraterritorially to any data controller or processor established outside Nigeria that processes personal data of Nigerian data subjects, imposes a tripartite cross-border transfer framework (adequacy decisions, Transfer Instruments, and statutory exceptions), mandates Data Protection Impact Assessments for AI and high-risk technologies, and carries a civil-penalty ceiling of 2% of annual gross revenue or NGN 10 million for designated data controllers and processors of major importance (DCPMIs), whichever is greater.

Mauritania promulgated Loi n° 2025-006 on 19 February 2025, comprehensively replacing the 2012 Investment Code (Loi n° 2012-052) with a three-tier incentive architecture — a Base Regime (SME + intermediate categories), a Development Poles Regime (designated geographic zones), and a Structuring Investments Regime (large-scale strategic projects above 200M MRU). The law was drafted with IFC/World Bank technical assistance, codifies national-treatment equality between domestic and foreign investors, provides fiscal-customs stability guarantees of up to 20 years, and establishes APIM as a digital single-window authority with ICSID/UNCITRAL arbitration pathways. As of July 2025, 19 projects (≈USD 120M declared investment, 939 estimated direct jobs) had been approved under the new framework.

Kuwait promulgated Decree-Law No. 7 of 2025 on 10 February 2025, amending Decree-Law No. 74 of 1979 on real estate ownership by non-Kuwaitis. The reform grants investment entities licensed under the Direct Investment Promotion Law (Decree-Law No. 116 of 2013, administered by KDIPA) the right to own real property necessary for carrying out and managing their licensed activities, or for housing their investors or employees — with an explicit prohibition on ownership for speculation purposes. A further Amiri decree will specify the implementing rules and the areas in which such property may be owned. The law is part of a coherent 2024–2025 KDIPA-regime modernisation package alongside the January 2024 branch-office-without-local-agent reform and KDIPA Decision No. 388 of 2024 on investment incentives and exemptions.

The Republic of Korea's National Assembly passed the Framework Act on the Development of Artificial Intelligence and the Establishment of a Foundation for Trustworthiness ("AI Basic Act") in plenary session on 26 December 2024, consolidating 19 separate AI bills tabled in the 22nd National Assembly. The statute was promulgated on 21 January 2025 and takes effect on 22 January 2026 after a one-year preparation period. Korea becomes the second jurisdiction worldwide — after the EU AI Act — to enact a comprehensive horizontal AI law, and the first in the Asia-Pacific. The Act establishes a risk-tiered regime targeting "high-impact" AI in healthcare, energy, public services, employment decisions, and generative-AI labelling, with extraterritorial reach over foreign providers whose systems affect the Korean market or users (mandatory local representative). It creates an AI Safety Institute, a national AI policy "control tower," and R&D / standardisation programmes under MSIT. Penalties are modest by international comparison — fines up to KRW 30 million plus a one-year grace period before full enforcement.

Malaysia's Personal Data Protection (Amendment) Act 2024 (Act A1727), gazetted 17 October 2024, enters its third and final commencement phase on 1 June 2025 per commencement order P.U.(B) 522/2024. Phase 3 activates sections 6 and 9 of the amending Act, which impose mandatory Data Protection Officer (DPO) appointment thresholds, a 72-hour breach-notification duty to the Commissioner, and a statutory data-portability right, bringing Malaysia's PDPA broadly into alignment with GDPR and the ASEAN Model AI Governance Framework.

Australia's first standalone cyber-security statute (Act No. 98 of 2024), passed by Parliament on 25 November 2024 and granted Royal Assent on 29 November 2024, with provisions commencing in tranches through 30 May 2025. The Act creates four binding regimes: (i) mandatory security-of-things standards for connected and IoT products supplied in Australia under regulations administered by the Department of Home Affairs; (ii) a mandatory ransomware / cyber-extortion payment disclosure regime requiring reporting business entities with annual turnover above AUD 3 million to notify the Australian Signals Directorate within 72 hours of any ransom payment made by or on behalf of the entity; (iii) a statutory Cyber Incident Review Board to conduct no-blame post-incident reviews of significant cyber incidents; and (iv) a "limited use" protection restricting how information voluntarily shared with the National Cyber Security Coordinator may be used by Commonwealth agencies. The Act implements core initiatives from the 2023-2030 Australian Cyber Security Strategy and affects every firm selling connected devices into Australia or operating above the turnover threshold in Australia.

On 6 September 2024 China's National Development and Reform Commission (NDRC) and Ministry of Commerce (MOFCOM) jointly issued Order No. 23, the Special Administrative Measures (Negative List) for Foreign Investment Access (2024 Edition), effective 1 November 2024. The 2024 list reduces nationwide restrictions from 31 to 29 entries, removing the last two manufacturing- sector restrictions (publication printing must be Chinese-controlled; investment in TCM-decoction steaming/roasting/calcination processes and confidential-formula proprietary Chinese-medicine production prohibited). Restrictions remain in services (telecommunications value-added, healthcare, education) and in 21 prohibited categories (news publishing, postal monopoly, fishing, gene therapy, tobacco). The 2021 edition is repealed on the same date.

The Bureau of Industry and Security (BIS) issued a final rule amending the Russia and Belarus sanctions under the Export Administration Regulations (EAR) to add License Exception Medical Devices (MED) at 15 CFR 740.23. The new exception authorises, without an individual licence, exports, reexports, and in-country transfers of EAR99 medical devices and EAR99 parts/components/accessories for exclusive use with such devices to Russia, Belarus, the temporarily occupied Crimea region of Ukraine, and the other covered regions of Ukraine. The exception carries verification conditions and excludes Entity List / military end-user recipients, "production" facilities, and any case where the exporter has knowledge the items will be diverted to weapons production.

On 21 March 2024, President William Ruto formally launched Kenya's Fourth Medium Term Plan 2023-2027 (MTP IV) at State House Nairobi, the final five-year implementation plan under the Kenya Vision 2030 blueprint. MTP IV is the operational vehicle for the Bottom-Up Economic Transformation Agenda (BETA), the Ruto administration's foundational industrial-policy and value-chain framework. The plan organises Kenya's industrial-policy push around five core BETA pillars and nine value chains: agro-processing (incl. edible-oil crops, leather, dairy, tea), textiles and apparel, housing and settlement, healthcare and pharmaceuticals, digital superhighway and creative economy, manufacturing (incl. automotive and EV motorcycle and vehicle assembly), MSME and cooperative sector strengthening, and blue-economy/natural-resource value addition. Implementation is anchored in County Aggregation and Industrial Parks (CAIPs) across all 47 counties and in the County Integrated Development Plans (CIDPs). MTP IV is the umbrella framework shaping Kenya's domestic industrial-incentive architecture, foreign-investment priorities, and AfCFTA positioning over 2023-2027. Subsequent sectoral instruments — including the Mining Royalty Collection and Management Regulations 2024 — operate within this policy perimeter. This is the first KE foundational industrial-policy filing in the register.

On 13 March 2024 the State Council issued the Action Plan on Promoting Large-Scale Equipment Renewal and Consumer Goods Trade-In as Guo Fa [2024] No. 7, distributed by NDRC alongside ten implementing ministries. Branded the "Two New" (两新) initiative, it is the flagship Xi/Li-era domestic-demand industrial-policy instrument structured around four action lines (equipment renewal, consumer-goods trade-in, recycling and circular utilisation, standards uplift) with twenty specific tasks and 2027 quantitative targets including ≥25% increase in equipment investment vs 2023 across industry, agriculture, construction, transport, education and healthcare. Funded by CNY 150bn of ultra-long-term special treasury bonds in 2024, expanded to CNY 300bn earmarked in 2025, the programme drove >CNY 1.3 trillion of consumer-goods trade-in transactions (autos, appliances, home furnishings, e-bikes) in its first year and is the central pillar of Beijing's response to the property-sector slowdown.

Belgium's Loi du 29 février 2024 (published in the Moniteur Belge on 27 May 2024, entering into force 1 June 2026) establishes the first comprehensive federal authorisation and traceability regime for pharmaceutical raw materials used by pharmacists in extemporaneous and magistral preparations. Manufacturers, importers, and distributors of covered materials must obtain AFMPS authorisation and comply with Good Manufacturing Practice and Good Distribution Practice standards; pharmacists may only source materials from authorised actors. The statute was enacted during Belgium's EU Council Presidency (H1 2024) and directly parallels the EU Critical Medicines Alliance architecture launched in Leuven on 24 April 2024, positioning Belgium as the first EU member state to operationalise a national supply-chain control layer for pharmaceutical compounding raw materials ahead of the forthcoming EU Critical Medicines Act.

OFAC amended § 510.512 of the North Korea Sanctions Regulations (31 CFR Part 510) to broaden the scope of authorized humanitarian activities for NGOs operating in North Korea, including permitting transactions with certain Government of North Korea entities where necessary to deliver authorized services. Three new general licenses were added: one for exports and re-exports of items licensed by the Commerce Department; one for agricultural commodities, medicine, and medical devices; and one for journalistic activities in North Korea. NGOs relying on the authorization must notify the State Department at least 30 days before commencing activity.

On 22 January 2024, Brazil's National Council for Industrial Development (CNDI), reactivated by President Lula in 2023, launched Nova Indústria Brasil (NIB) — Brazil's first comprehensive national industrial policy since the 2011-2014 Plano Brasil Maior. The framework commits roughly R$300 billion (~USD 60 billion) in financing through 2026, distributed across loans, non-refundable grants and equity participations administered by BNDES (Brazilian Development Bank), Finep (Research and Projects Financing Company) and Embrapii (Brazilian Industrial Research and Innovation Company), with quantitative targets running to 2033. The R$300bn envelope combines R$106bn announced at the first CNDI meeting in July 2023 with R$194bn redirected from existing budget lines. NIB is structured around six "missions": (1) sustainable and digital agro-industrial chains, (2) health-industrial complex resilience (medicines, vaccines, devices), (3) urban infrastructure and green mobility, (4) digital transformation and Industry 4.0 including semiconductors, (5) bioeconomy and energy transition, and (6) defence, sovereignty and national-security technologies. Two presidential decrees signed the same day establish local-content preferences for New PAC public-procurement bids and create an Interministerial Public Procurement Commission. As of February 2025, BNDES had approved R$220bn in NIB-aligned operations, and the plan has anchored downstream sectoral programmes including Brasil Semicon, the Mover automotive programme and Mais Inovação.

Signed by President Javier Milei and the entire cabinet on 20 December 2023 and published in the Boletín Oficial extraordinario on 21 December 2023, Decreto de Necesidad y Urgencia 70/2023 declares a public emergency across economic, financial, fiscal, administrative, pension, tariff, sanitary, and social matters until 31 December 2025 (Article 1) and enacts 366 articles across 16 titles that fundamentally restructure Argentina's regulatory framework. The DNU repeals or amends dozens of statutes to deregulate foreign trade (repealing the Compre Nacional buy-preference law Ley 18.875 and the price-control framework Ley 27.345), opens privatisation of state enterprises (Aerolíneas Argentinas, ENARSA, Banco Nación, Correo Argentino, Trenes Argentinos), dismantles the Ley de Abastecimiento price-control regime, liberalises civil aviation cabotage to foreign carriers, deregulates hydrocarbons export and mining permitting, and replaces the severance-pay regime with a capitalisation-fund system. It is the foundational enabling framework for all subsequent Milei-administration deregulatory instruments filed on the IPTM register, including RIGI (Law 27.742), Decreto 38/2025, Decreto 449/2025, and Decreto 563/2025.

Saudi Arabia's Personal Data Protection Law (PDPL), issued under Royal Decree M/19 (16 September 2021) and substantively amended by Royal Decree M/148 (27 March 2023), entered into force on 14 September 2023 with a one-year transition period that ended on 14 September 2024 — at which point the Saudi Data & Artificial Intelligence Authority (SDAIA) became the binding regulator with full enforcement powers. Alongside the Implementing Regulations and the Regulations on the Transfer of Personal Data Outside the Kingdom (both issued 7 September 2023), SDAIA published in 2024 a set of four pre-approved Standard Contractual Clauses templates (C2C, C2P, P2P, P2C) governing cross-border transfers. The regime establishes consent requirements, DPO appointment, a 72-hour breach notification duty, and prior-clearance / SCC-or-BCR-style conditions on personal-data exports out of Saudi Arabia.

On 9 June 2023 the National Assembly of the Republic of Slovenia adopted Zakon o spremembah in dopolnitvah Zakona o spodbujanju investicij — ZSInv-C (Act on Amendments to the Investment Promotion Act), published in Uradni list RS No. 65/23 on 17 June 2023 and entering into force on 1 July 2023. The amendment converts Slovenia's temporary COVID-era inward FDI screening regime (originally introduced under ZIUOPDVE in 2020 and set to expire June 2023) into a permanent, horizontal screening framework administered by the Ministry of Economy, Tourism and Sport (MGTŠ). Non-EU (third-country) investors acquiring ≥10% voting rights or control in Slovenian entities operating in sectors listed under EU Regulation 2019/452 — including critical infrastructure, critical technology and dual-use goods, critical inputs, sensitive data, media, and health/AI/robotics — must submit a mandatory pre-closing notification; the ministry has suspensory power and may block, condition, or unwind transactions on grounds of security or public order. A subsequent 2024 amendment (Uradni list RS No. 31/24) broadened scope by redefining "corporate entity" to capture indirect investments channelled via branches of foreign entities established in other EU member states.

On 20–21 December 2022 OFAC published two final rules (87 FR 78470 and 87 FR 78484) amending regulations across more than 30 sanctions programs to add general licenses (GLs) authorising four categories of humanitarian activity: (1) certain NGO transactions for disaster relief, health, democracy support, education, environmental protection, and peacebuilding; (2) provision of agricultural commodities, medicine, medical devices, replacement parts, and software updates for medical devices to blocked persons for personal, non-commercial use; (3) US government official-business transactions; and (4) official-business transactions of designated international organisations (e.g. UN, ICRC). The rules amended 29 CFR parts spanning Nicaragua, Iraq, Somalia, South Sudan, Yemen, and more than two dozen other sanctioned programs. The NGO GL excludes knowing fund transfers to blocked persons unless specified criteria are met, preserving the core blocking perimeter while lowering humanitarian-access friction.

On 4 August 2022 OFAC formally published in the Federal Register nine general licenses (GLs 17–25) that had previously been made available only on OFAC's website under EO 14065 (Donetsk/Luhansk regions) and, for GL 25, also EO 13685 (Crimea). GL 17, which authorised wind-down of Donetsk/Luhansk transactions, had already expired on 23 March 2022. GLs 18–25 remain in force and authorise a structured set of humanitarian and civil-society carve-outs — covering agricultural commodities, medicine and medical devices, telecommunications, official international organisation business, personal remittances, internet-based communications, NGO activities, civil maritime services, and journalistic activities — within the otherwise restricted territory of Crimea, the so-called Donetsk People's Republic (DNR), and the Luhansk People's Republic (LNR).

France 2030 is a €54 billion public investment plan unveiled by President Emmanuel Macron on 12 October 2021 to fund breakthrough innovation and reindustrialisation across ten strategic priorities — small modular nuclear reactors, green hydrogen, low-carbon transport (incl. two million EVs/year), food/agritech, twenty drug therapies for cancer and chronic disease, cultural industries, space, deep-sea exploration, semiconductors and electronic components, and robotics/digital (AI/cloud). Two cross-cutting rules require 50% of investment to flow to decarbonisation and 50% to emerging innovative players. Operationalised from the 2022 budget law, the plan is coordinated by the Secrétariat général pour l'investissement (SGPI) under the Prime Minister and delivered by ANR, ADEME, Bpifrance and Caisse des Dépôts / Banque des Territoires.

The Personal Information Protection Law of the People's Republic of China (中华人民共和国个人信息保护法 — PIPL) was adopted at the 30th meeting of the 13th NPC Standing Committee on 20 August 2021 and entered into force on 1 November 2021, constituting the third and final pillar of China's cybersecurity and data-governance regulatory trinity alongside the Cybersecurity Law (2016) and the Data Security Law (2021). The PIPL is China's comprehensive personal-information statute establishing consent-based and necessity-based legal bases for PI processing, a tiered cross-border personal-data transfer regime (CAC security assessment / PI protection certification / Standard Contractual Clauses), extraterritorial application (Art. 3) to non-Chinese controllers offering services to or analysing the behaviour of PRC residents, and a heightened protection regime for sensitive personal information and data of minors under 14. It mandates data-protection impact assessments, personal-information-protection-officer obligations at designated handlers, breach notification, and a full suite of data-subject rights including access, rectification, deletion, portability, objection, and automated- decision-making opt-out. Article 53 requires overseas controllers to establish a domestic representative or designated entity in China, providing a domestic enforcement counterparty.

Decreto-Legge 15 marzo 2012 n. 21 (GU n. 63 of 15 March 2012), converted with amendments into Legge 11 maggio 2012 n. 56 (GU n. 111 of 14 May 2012), establishes Italy's "Golden Power" special-powers regime — the foundational statute authorising the Italian Government to impose conditions on, veto, or prescribe remedies for corporate transactions in strategic sectors. The decree marked Italy's transition from a golden-share model (applicable only to privatised companies) to a sector-wide golden-power model applicable to any company carrying out activities of strategic relevance. Administered by the Presidenza del Consiglio dei Ministri (DICA), the regime has been progressively extended from its original defence + national-security + energy/transport/ communications scope to cover 5G, cloud, critical-raw-materials, financial-credit-insurance, agri-food, healthcare, media, space, and AI through a series of amending decrees from 2019 to 2026.